|135.92|| +0.93 / +0.69%|
Illumina, Inc. develops, manufactures and markets integrated systems for the analysis of genetic variation and function. The company provides sequencing and array-based solutions for genetic analysis in addition to selling products, it provide genotyping, NIPT and whole-genome sequencing services. Its customers include leading genomic research centers, academic institutions, government laboratories, hospitals, and reference laboratories as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic, and consumer genomics companies. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.
|Jay T. Flatley||Chairman & Chief Executive Officer|
|Francis A. deSouza||President & Director|
|Robert P. Ragusa||Senior Vice President-Global Quality & Operations|
|Marc A. Stapley||EVP, Chief Financial & Administrative Officer|
|Mostafa Ronaghi||Chief Technology Officer & Senior Vice President|